Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$319K Sell
2,483
-3,177
-56% -$372K 0.31% 113
2026
Q1
$681K Sell
5,660
-5,986
-51% -$691K 0.77% 42
2025
Q4
$1.23M Buy
+11,646
New +$1.09M 1.4% 23
2024
Q3
$1.36M Hold
11,988
1.82% 11
2024
Q2
$1.48M Sell
11,988
-224
-2% -$28.9K 1.71% 11
2024
Q1
$1.61M Buy
+12,212
New +$1.51M 1.75% 8

Other funds holding MRK

Verdad Advisers's MRK Position: Q2 2026 in Review

Verdad Advisers reduced its Merck (MRK) stake by 56% in Q2 2026, selling an estimated $372K and leaving 2,483 shares worth $319K. The position accounts for 0.31% of the portfolio, ranked #113.

Verdad Advisers first reported a position in MRK in Q1 2024 and has held it in 6 quarters since. The position peaked at $1.61M in Q1 2024. 3,832 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Verdad Advisers held 2,483 shares of Merck worth $319K as of Q2 2026.
  • Verdad Advisers sold 3,177 Merck shares in Q2 2026, an estimated $372K.
  • Merck made up 0.31% of Verdad Advisers's portfolio in Q2 2026, its #113 holding.
  • Verdad Advisers first reported a position in Merck in Q1 2024 and has held it in 6 quarters since.
  • Verdad Advisers's Merck position peaked at $1.61M in Q1 2024.
  • 3,832 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Verdad Advisers's 13F filing for Q2 2026, filed 14 Aug 2026.